Tuesday, January 21, 2025 11:43:12 AM
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/03/2025 05:15:35 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:40:20 PM
- CytoDyn Announces Resolution of Class Action Lawsuit • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 11/24/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 10:15:12 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/04/2025 10:15:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2025 10:15:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 01:38:18 PM
- CytoDyn Secures $30 Million Commitment from Yorkville Advisors • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2025 12:30:21 PM
- CytoDyn to Present at the LD Micro Main Event XIX Investor Conference • GlobeNewswire Inc. • 10/09/2025 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/30/2025 09:15:05 PM
- September 2025 Letter to Shareholders • GlobeNewswire Inc. • 09/30/2025 12:30:55 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/29/2025 08:45:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/29/2025 08:30:48 PM
- CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity • GlobeNewswire Inc. • 09/25/2025 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/19/2025 08:30:44 PM
- CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity • GlobeNewswire Inc. • 09/16/2025 12:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/25/2025 09:04:52 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/25/2025 08:34:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 09:10:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 09:05:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/15/2025 09:15:25 PM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • IONI • Dec 4, 2025 8:30 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now • PFE • Dec 2, 2025 9:00 AM
Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order • BLO • Dec 2, 2025 8:50 AM
